December 2nd, 2009
· Shenzhen will spend Yn6bn (£530m) to reclaim land from the sea for the expansion of Shenzhen International Airport. The expansion will allow a three-fold rise in cargo and mail throughput at the airport. Passenger handling capacity will increase to 36 million people a year.
· China State Construction Engineering Corporation has succeeded in bidding for the $100 million New York City’s East Side Access metro ventilation project. It had previously won two tenders worth a combined $2.1 billion in Greater New York, making the company the only Chinese-funded contractor doing business in the mainstream construction industry of the United States.
Sources: CBBC, Xinhua, Financial Times, Wall Street Journal, FCO Country Updates, The China Perspective and other news sources.
Posted in China, Construction Industry, Engineering, Transport Sector, USA | No Comments »
October 23rd, 2009
-
China will need to buy 3,710 aeroplanes over the next 20 years, spending around US$390 trillion, said a recent forecast. The growth of passenger and cargo air transportation will increase China’s aircraft fleet by more than three times to equal the current number of aircraft in Europe.
-
China’s domestic aviation market has continued to grow during the first half of 2009. At Beijing’s Capital International Airport, passenger volume from January to June rose by 20% over the same period last year.
-
Taikoo Sichuan Aircraft Engineering Services Company has begun the construction of an Airbus maintenance base in Chengdu. The plant is expected to become the biggest specialised maintenance base for Airbus in China, if not the whole of the Asian region, after its completion.
For more information on our aerospace market research services in China and Asia, please visit: http://b2binternational.com/China/b2bsectors/aerospace.php
Sources: CBBC, Xinhua, Financial Times, Wall Street Journal, FCO Country Updates and other news sources.
Posted in Aerospace, Asia, China, Engineering, Europe, Growth | No Comments »
February 5th, 2009
In the latest issue of Asia Research, Alaric Fairbanks, General Manager of B2B International in Beijing, talks about setting up and running a market research company in China. Over the next three blog posts, we will serialize his interview:
Tell me about B2B International
As the name implies, we work in b2b markets and are international. We are a specialist business-to-business market research company, with our group headquarters in the United Kingdom and subsidiaries in New York and, of course, Beijing. Our focus is exclusively b2b, and although we cover all b2b markets, we have particular strengths in chemicals, pharmaceuticals, engineering, construction and financial services. In terms of services, our main focus is on full service research, covering market assessment, segmentation, customer satisfaction, new product development, competitor analysis and pricing studies, and our major clients are multi-national firms engaged in b2b markets. In Asia we also complement our full service work with data collection.
What were the main challenges when you first set up the business?
We set up permanently here in 2006 and in many ways the challenges we faced when setting up in China were similar to those that many foreign-invested businesses in China, including some of our clients, face. These include recruiting staff, adapting and integrating systems and working styles into the local conditions, and on a practical level finding reliable partners or suppliers, particularly in areas such as IT and financial services. I regard these as important challenges to deal with, but the primary issue from day one was, and remains, generating business and delivering quality work.
Look out for Part 2 of the interview in our next blog post.
Posted in Alaric Fairbanks, Asia, B-to-B, Chemicals Research, China, Competitor Analysis, Construction Industry, Customer Satisfaction, Data Collection, Engineering, Financial Services, Full Service Research, Global Research, International, Market Assessment, Market Research, Market Research China, New Product Development, Pharmaceutical, Pricing Strategy, Segmentation, UK, USA | No Comments »